Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Merck
Express Scripts
Boehringer Ingelheim
Dow

Last Updated: May 27, 2022

Alvogen Company Profile


✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ALVOGEN, and what generic and branded alternatives to ALVOGEN drugs are available?

ALVOGEN has fifty-eight approved drugs.



Drugs and US Patents for Alvogen

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alvogen BUPRENORPHINE HYDROCHLORIDE buprenorphine hydrochloride FILM;BUCCAL 211594-007 Aug 3, 2021 DISCN No No See Plans and Pricing See Plans and Pricing
Alvogen DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate TABLET;ORAL 207388-003 Jul 28, 2017 AB RX No No See Plans and Pricing See Plans and Pricing
Alvogen ACETYLCYSTEINE acetylcysteine SOLUTION;INHALATION, ORAL 204674-001 Feb 11, 2014 AN RX No No See Plans and Pricing See Plans and Pricing
Alvogen OXYCODONE AND ACETAMINOPHEN acetaminophen; oxycodone hydrochloride TABLET;ORAL 202677-002 Jul 26, 2012 AA RX No No See Plans and Pricing See Plans and Pricing
Alvogen BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE buprenorphine hydrochloride; naloxone hydrochloride FILM;BUCCAL, SUBLINGUAL 205954-001 Jan 24, 2019 AB RX No No See Plans and Pricing See Plans and Pricing
Alvogen BUTALBITAL, ACETAMINOPHEN AND CAFFEINE acetaminophen; butalbital; caffeine TABLET;ORAL 204984-001 Jan 10, 2017 AA RX No No See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Alvogen

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alvogen TRANDATE labetalol hydrochloride TABLET;ORAL 018716-002 Aug 1, 1984 4,066,755 See Plans and Pricing
Alvogen LIDEX fluocinonide OINTMENT;TOPICAL 016909-002 Approved Prior to Jan 1, 1982 4,017,615 See Plans and Pricing
Alvogen SPECTAZOLE econazole nitrate CREAM;TOPICAL 018751-001 Dec 23, 1982 3,717,655 See Plans and Pricing
Alvogen LIDEX fluocinonide CREAM;TOPICAL 016908-002 Approved Prior to Jan 1, 1982 3,592,930 See Plans and Pricing
Alvogen TAMBOCOR flecainide acetate TABLET;ORAL 018830-002 Oct 31, 1985 3,900,481 See Plans and Pricing
Alvogen TAMBOCOR flecainide acetate TABLET;ORAL 018830-003 Jun 3, 1988 4,642,384 See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Boehringer Ingelheim
Moodys
Baxter
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.